MERS CoV infection in two renal transplant recipients: Case report

American Journal of Transplantation

Volumn 15, Issue 4, 2015, Pages 1101-1104

  Alghamdi, M ^a   Mushtaq, F ^a   Awn, N ^a   Shalhoub, S ^b  

^a KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

^b KING FAHD ARMED FORCES HOSPITAL   (Saudi Arabia)

Author keywords

Clinical research; infection and infectious agents; infectious disease; kidney disease: infectious; practice; viral

Indexed keywords

AZATHIOPRINE; CEFTRIAXONE; COTRIMOXAZOLE; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; PEGINTERFERON ALPHA2A; PREDNISONE; RIBAVIRIN; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CLINICAL FEATURE; CORONAVIRUS INFECTION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DYSPNEA; ENTEROBACTERIACEAE INFECTION; FATIGUE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LOADING DRUG DOSE; MALE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RESPIRATORY TRACT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SORE THROAT; THORAX RADIOGRAPHY; THROAT CULTURE; UPPER GASTROINTESTINAL BLEEDING; VIRUS PNEUMONIA; COMPLICATION; CORONAVIRIDAE INFECTION;

ADULT; CORONAVIRIDAE INFECTIONS; CORONAVIRUS INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; MALE;

EID: 84925234696     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13085     Document Type: Article

References (15)

1. Lepiller Q, Barth H, Lefebvre F, et al. High incidence but low burden of coronaviruses and preferential associations between respiratory viruses. J Clin Microbiol 2013; 51: 3039-3046.
2. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367: 1814-1820.
3. Memish ZA, Al-Tawfiq JA, Makhdoom HQ, et al. Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: A prospective descriptive study. Clin Microbiol Infect 2014; 20: 469-474.
4. Al-Tawfiq JA, Hinedi K, Ghandour J, et al. Middle East Respiratory Syndrome-Coronavirus (MERS-CoV): A case-control study of hospitalized patients. Clin Infect Dis 2014; 59: 160-165.
5. Mailles A, Blanckaert K, Chaud P, et al. First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill 2013; 18.
6. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study. Lancet Infect Dis 2013; 13: 752-761.
7. Corman VM, Eckerle I, Bleicker T, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill 2012; 17.
8. World Health Organization (WHO). Revised interim case definition for reporting to WHO-Middle East respiratory syndrome coronavirus (MERS-CoV). Interim case definition as of 3 July 2013. Geneva: WHO, 2013. Available at: http://www.who.int/csr/disease/coronavirus-infections/case-definition/en/index.html. Accessed July 20, 2013.
9. Centers for Disease Control and Prevention (CDC). Middle East Respiratory Syndrome (MERS). Case Definitions. Available at: http://www.cdc.gov/coronavirus/mers/case-def.html. Accessed June 12, 2013.
10. Eckerle I, Muller MA, Kallies S, Gotthardt DN, Drosten C., In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) coronavirus infection. Virol J 2013; 10: 359.
11. Falzarano D, de Wit E, Martellaro C, Callison J, Munster VJ, Feldmann H., Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin. Sci Rep 2013; 3: 1686.
12. Falzarano D, de Wit E, Rasmussen AL, et al. Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med 2013; 19: 1313-1317.
13. Al-Tawfiq JA, Momattin H, Dib J, Memish ZA., Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: An observational study. Int J Infect Dis 2014; 20: 42-46.
14. Hart BJ, Dyall J, Postnikova E, et al. Interferon-beta and mycophenolic acid are potent inhibitors of middle east respiratory syndrome coronavirus in cell-based assays. J Gen Virol 2014; 95: 571-577.
15. Assiri A, McGeer A, Perl TM, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013; 369: 407-416.